Qinghua Wu Selected Research

diacetoxyscirpenol

1/2020	From hypoxia and hypoxia-inducible factors (HIF) to oxidative stress: A new understanding of the toxic mechanism of mycotoxins.
1/2020	Type A Trichothecene Diacetoxyscirpenol-Induced Emesis Corresponds to Secretion of Peptide YY and Serotonin in Mink.
12/2017	Trichothecenes: immunomodulatory effects, mechanisms, and anti-cancer potential.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Qinghua Wu Research Topics

Disease

34	Neoplasms (Cancer) 06/2022 - 01/2004
10	Inflammation (Inflammations) 01/2022 - 06/2013
8	Hypoxia (Hypoxemia) 01/2022 - 10/2017
7	Vomiting 01/2022 - 12/2011
6	Neoplasm Metastasis (Metastasis) 10/2022 - 09/2011
6	Ovarian Neoplasms (Ovarian Cancer) 02/2021 - 07/2006
6	Carcinoma (Carcinomatosis) 01/2019 - 11/2003
5	Infections 10/2022 - 10/2018
5	Hemorrhage 01/2022 - 10/2017
5	Myocardial Infarction 01/2021 - 01/2016
5	Sepsis (Septicemia) 05/2019 - 06/2013
4	Myocardial Ischemia (Ischemic Heart Diseases) 04/2022 - 01/2015
4	Cardiomyopathies (Cardiomyopathy) 11/2021 - 10/2019
4	Cardiotoxicity 06/2021 - 06/2017
4	Hypertension (High Blood Pressure) 01/2021 - 07/2019
4	Heart Failure 12/2020 - 01/2019
4	Colonic Neoplasms (Colon Cancer) 10/2020 - 09/2011
4	Carcinogenesis 05/2019 - 01/2004
3	Necrosis 06/2022 - 11/2017
3	Ischemia 04/2022 - 10/2016
3	Atherosclerosis 01/2022 - 06/2011
3	Takayasu Arteritis (Arteritis, Takayasu's) 11/2021 - 03/2010
3	Fibrosis (Cirrhosis) 06/2021 - 08/2018
3	Poisoning 01/2021 - 08/2018
3	Mitochondrial Diseases (Mitochondrial Disease) 11/2020 - 12/2017
3	Atrial Fibrillation 01/2020 - 01/2020
3	Stroke (Strokes) 01/2020 - 07/2019
2	Coronary Artery Disease (Coronary Atherosclerosis) 04/2022 - 06/2020
2	Infarction (Infarctions) 04/2022 - 09/2019
2	Reperfusion Injury 04/2022 - 01/2015
2	Type 2 Diabetes Mellitus (MODY) 01/2022 - 01/2022
2	Foodborne Diseases 01/2022 - 07/2020
2	Diabetes Mellitus 01/2022 - 07/2019
2	Headache (Headaches) 01/2022 - 02/2018
2	Breast Neoplasms (Breast Cancer) 02/2021 - 12/2017
2	Proteinuria 01/2021 - 01/2018
2	Human Influenza (Influenza) 01/2021 - 04/2019
2	Body Weight (Weight, Body) 10/2020 - 12/2017
2	Liver Neoplasms (Liver Cancer) 01/2020 - 12/2016
2	Autoimmune Diseases (Autoimmune Disease) 01/2020 - 10/2019
2	Atherosclerotic Plaque (Atheroma) 01/2019 - 06/2011
2	Obesity 01/2018 - 01/2016
2	Hemophilia A (Haemophilia) 10/2017 - 08/2016
2	Diarrhea 06/2017 - 02/2017

Drug/Important Bio-Agent (IBA)

14	T-2 Toxin (T 2 Toxin)IBA 01/2022 - 12/2014
11	Proteins (Proteins, Gene)FDA Link 01/2022 - 11/2003
9	deoxynivalenolIBA 01/2022 - 12/2011
9	MycotoxinsIBA 09/2021 - 01/2011
6	CytokinesIBA 01/2022 - 08/2018
5	TrichothecenesIBA 01/2022 - 12/2014
5	MicroRNAs (MicroRNA)IBA 12/2021 - 11/2014
5	Pharmaceutical PreparationsIBA 11/2021 - 01/2017
5	trichotheceneIBA 01/2020 - 10/2015
4	Glucose (Dextrose)FDA LinkGeneric 06/2022 - 07/2019
4	LipidsIBA 01/2022 - 06/2011
4	Long Noncoding RNAIBA 12/2021 - 01/2019
4	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 01/2004
3	Small Interfering RNA (siRNA)IBA 10/2022 - 09/2011
3	JNK Mitogen-Activated Protein KinasesIBA 01/2022 - 11/2019
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2022 - 12/2017
3	Biomarkers (Surrogate Marker)IBA 11/2021 - 09/2011
3	CreatinineIBA 01/2021 - 01/2018
3	diacetoxyscirpenolIBA 01/2020 - 12/2017
3	Sirtuin 1IBA 01/2020 - 06/2013
3	Messenger RNA (mRNA)IBA 12/2019 - 10/2017
3	Transcription Factors (Transcription Factor)IBA 01/2019 - 12/2017
2	Eosine Yellowish-(YS) (Eosin)IBA 10/2022 - 12/2016
2	Insulin (Novolin)FDA Link 10/2022 - 01/2020
2	Hematoxylin (Haematoxylon)IBA 10/2022 - 12/2016
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 04/2022 - 09/2019
2	EmeticsIBA 01/2022 - 01/2022
2	Peptides (Polypeptides)IBA 01/2022 - 01/2022
2	Ruthenium RedIBA 01/2022 - 01/2022
2	Serotonin (5 Hydroxytryptamine)IBA 01/2021 - 01/2020
2	neuropeptide Y2 receptorIBA 01/2021 - 01/2020
2	5-HT3 Serotonin Receptors (5 HT3 Receptor)IBA 01/2021 - 01/2020
2	Competitive Endogenous RNAIBA 01/2021 - 10/2019
2	LigandsIBA 01/2021 - 10/2007
2	Granisetron (Kytril)FDA LinkGeneric 01/2021 - 01/2020
2	sacubitril and valsartan sodium hydrate drug combinationIBA 01/2021 - 12/2020
2	baicalinIBA 01/2021 - 01/2021
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021 - 01/2019
2	Angiotensin Receptor AntagonistsIBA 12/2020 - 10/2016
2	Immunologic Factors (Immunomodulators)IBA 11/2020 - 02/2018
2	RNA (Ribonucleic Acid)IBA 10/2020 - 10/2007
2	4,4- difluoro- 4- bora- 3a,4a- diaza- s- indacene (BODIPY)IBA 10/2020 - 06/2020
2	Dexmedetomidine FDA Link 08/2020 - 01/2015
2	HomocysteineIBA 01/2020 - 07/2019
2	Peptide YYIBA 01/2020 - 01/2020
2	AnticoagulantsIBA 01/2020 - 01/2020
2	Warfarin (Coumadin)FDA LinkGeneric 01/2020 - 01/2020
2	Factor VIII (Coagulation Factor VIII)IBA 10/2017 - 08/2016
2	Interleukin-11 Receptors (Interleukin 11 Receptor)IBA 12/2016 - 09/2012
2	Milrinone (Primacor)FDA LinkGeneric 01/2016 - 11/2015
2	esmolol (Brevibloc)FDA LinkGeneric 01/2016 - 11/2015

Therapy/Procedure

17	Therapeutics 01/2022 - 06/2011
3	Phototherapy (Light Therapy) 10/2020 - 06/2020
3	Ligation 09/2019 - 12/2017
2	Immunotherapy 01/2022 - 01/2021
2	Lasers (Laser) 10/2020 - 06/2020